Current clinician perspective on non-vitamin K antagonist oral anticoagulant use in challenging clinical cases

• Principais autores: Uğur Önsel Türk (Autor), Rezzan Deniz Acar (Autor), Taylan Akgün (Autor), Volkan Emren (Autor), Selçuk Kanat (Autor), Emir Karacağlar (Autor), Alper Kepez (Autor), Şeref Kul (Autor), Erdem Özel (Autor), Evrim Şimşek (Autor), Selcen Yakar Tülüce (Autor), Kamil Tülüce (Autor), A. John Camm (Autor)
• Formato: Livro
• Publicado em: KARE Publishing, 2020-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objective: The evolution of non-vitamin K antagonist anticoagulants (NOACs) has changed the horizon of stroke prevention in atrial fibrillation (SPAF). All 4 NOACs have been tested against dose-adjusted warfarin in well-designed, pivotal, phase III, randomized, controlled trials (RCTs) and were appr...